To include this story in your blog or website —
Science Centric (10 Dec 2010 20:45 GMT) - A high level of circulating tumour cells (CTCs) - cells that have detached from a tumour and are circulating in the body through the blood - are an independent prognostic marker in metastatic breast cancer as first-line therapy. In addition, persistence of high CTC level during therapy was found to be an early marker of poor outcome…
— copy and paste the formatted text using the form to the left.